Related Experiment Video

Updated: Jul 18, 2025

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.4K

Immunotherapy in Melanoma: Recent Advancements and Future Directions

Meghan J Mooradian1, Ryan J Sullivan1

  • 1Massachusetts General Hospital Cancer Center, Boston, MA 02114, USA.

Cancers
|August 26, 2023
PubMed

Insights

Immune checkpoint inhibitors have transformed melanoma treatment, improving survival rates. Research now focuses on overcoming resistance and personalizing therapies through novel combination strategies for better patient outcomes.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Immune checkpoint inhibitors (ICIs) have revolutionized melanoma treatment, significantly improving patient survival rates.
  • Five-year overall survival for unresectable melanoma now exceeds 50% due to ICI advancements.
  • Despite progress, challenges remain in managing de novo and acquired resistance to therapies.

Purpose of the Study:

  • To review current advancements in malignant melanoma treatment.
  • To highlight novel combination strategies for enhancing therapeutic efficacy.
  • To discuss approaches for overcoming resistance to immune checkpoint inhibition.

Main Methods:

  • Literature review of recent clinical trials and research findings.
  • Analysis of emerging combination therapies in melanoma treatment.
  • Synthesis of data on resistance mechanisms and personalized treatment approaches.

Main Results:

  • Immune checkpoint inhibition has led to substantial improvements in melanoma patient survival.
  • Novel combination strategies are showing promise in enhancing treatment responses.
  • Personalized therapeutic approaches are crucial for managing resistance.

Conclusions:

  • Immune checkpoint inhibitors represent a major breakthrough in melanoma care.
  • Future research should prioritize combination therapies and personalized medicine to further improve outcomes.
  • Addressing resistance remains a key challenge in optimizing melanoma treatment.
Keywords:
LAG-3TILTLR-9VEGFimmunotherapymelanomavaccine

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.5K
Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation05:33

Author Spotlight: Recreating Melanoma Complexity with Patient-Derived Organoids for Immunotherapy Evaluation

Published on: September 6, 2024

1.5K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
556
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
400
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.2K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K